Literature DB >> 11920766

Hard to swallow dry: kinetics and mechanism of the anhydrous thermal decomposition of acetylsalicylic acid.

Gregory T Long1, Sergey Vyazovkin, Nicoleigh Gamble, Charles A Wight.   

Abstract

The methods of thermal analysis and mass spectrometry have been used to study the kinetics and mechanism of the anhydrous thermal decomposition of acetylsalicylic acid. Both thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) show that decomposition occurs in two steps. Mass-spectrometric analysis of the residue left after the first decomposition step (approximately equal to 60% mass loss) suggests that in the condensed phase, acetylsalicylic acid decomposes by first forming linear oligomers that are further converted into cyclic oligomers. Model-free isoconversional kinetic analysis of TGA traces has been used to determine global activation energies as a function of the extent of reaction. This method of analysis has also been used to make kinetic predictions of shelf life at ambient temperatures (20-40 degrees C) under anhydrous conditions for acetylsalicylic acid. Our estimate of a shelf life of 876 days (approximately equal to 2.4 years) for 5% decomposition at 30 degrees C is in good agreement with shelf lives of 2-3 years that are stamped on over-the-counter aspirin bottles. Hence, this approach can be used to systematically study the factors that determine the decomposition kinetics of aspirin and may be used for express screening of pharmaceuticals in order to identify those with desirable thermal stabilities. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920766     DOI: 10.1002/jps.10029

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.

Authors:  Kenneth C Waterman; Anthony J Carella; Michael J Gumkowski; Patrick Lukulay; Bruce C MacDonald; Michael C Roy; Sheri L Shamblin
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

2.  Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin.

Authors:  Blaž Robnik; Blaž Likozar; Baifan Wang; Tijana Stanić Ljubin; Zdenko Časar
Journal:  Pharmaceutics       Date:  2019-09-02       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.